Opens in a new tab

Herbert Smith Freehills Kramer LLP v Insulet (CFI, 16 October 2025)

Date16 October 2025
CourtCFI
DivisionMilan (IT) Central Division- Section
Type of actionApplication RoP262.1 (b)
Case number(s)UPC_CFI_941/2025
Registry referenceUPC-CFI-0000941/2025
PartiesHerbert Smith Freehills Kramer LLP v. 1) Insulet Corporation; 2) EOFLOW Co., Ltd.

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

In an order of 16 October 2025, the judge-rapporteur of the Milan Central Division partly granted Herbert Smith Freehills Kramer’s request for access to the file of the proceedings Insulet v EOFLOW (UPC_CFI_380/2024). Only Insulet’s application and EOFLOW’s objection are to be provided, in redacted form, within five days. Access to the other eleven items requested, mostly exhibits, was refused. The order confirms that a third party relying on a mere need to understand the decision will obtain the pleadings, but seldom the exhibits.

Question

Does a law firm wishing to understand a decision better in order to advise its clients show a sufficient interest under Rule 262.1(b) to obtain access to the pleadings and exhibits?

Decision

Only in part. The judge examines the applicant’s specific interest and grants access only to documents that are essential to the stated purpose, weighing it against the parties’ legitimate interests and the general interest of justice, which includes preventing abusive requests. The redacted pleadings are enough to understand the decision. The exhibits are not needed and the risk of a scoping exercise prevails. Documents not mentioned in the decision of 22 July 2025 add nothing, and disclosing them would be disproportionate. Protected material (trade secrets, personal data) remains protected after the decision on the merits. No costs order was made, access proceedings not being contentious.

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Arts 45 and 58
Rules of Procedure
Rules 262.1(b), 262.2 and 262A
Case law cited
Ocado Innovation v Autostore, Court of Appeal, 10 April 2024, Amgen v Sanofi-Aventis Deutschland, Munich Central Division, 20 September 2023, Abbott Diabetes Care v Sibio, Court of Appeal (UPC_CoA_480/2024 and UPC_CoA_481/2024)

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Supplementary protection certificate (SPC), Biosimilar medicinal product, Launch at risk.

Dhenne Avocats blog: Pharmaceutical patents and the UPC: is the Court hostile to them?.

Publications by Matthieu Dhenne: The Launch Letter: How Generics and Biosimilars Should Write to Avoid UPC Urgency (Kluwer Patent Blog).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CFI_941/2025 official number

Follow this case

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Application RoP262.1 (b)
Outcome (Dhenne Avocats summary)
Le cabinet demandeur obtient copie expurgée de la demande d'Insulet et de l'objection d'EOFLOW. L'accès aux annexes est refusé, faute d'être indispensable au but invoqué.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.